Clinical Trials Browser

Unknown × Drug Therapy × Head & Neck × Clear all

NCT05011227 2024-03-06

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT05992610 2023-08-15

iCHRTL

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT03691441 2023-05-17

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

Phase 4 Unknown

Oropharyngeal Neoplasms

NCT04359199 2023-02-10

QUASAR

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT04398056 2022-07-06

Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT05136768 2021-11-29

LM-HNSCC

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT04826679 2021-04-01

Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT03989830 2020-10-23

SLICER

Phase 2 Unknown

Head and Neck Neoplasms

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT03923842 2020-02-17

Dern

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT03020329 2019-08-07

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT03890185 2019-03-26

Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC

Phase 2 Unknown

Nasopharyngeal Neoplasms

NCT03656965 2018-09-04

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Phase 3 Unknown

Nasopharyngeal Carcinoma

NCT03344068 2017-12-22

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

Phase 2/3 Unknown

Nasopharyngeal Carcinoma

NCT03045484 2017-11-29

Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy

Phase NA Unknown

Nasopharyngeal Carcinoma

NCT03177902 2017-06-07

Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

Thyroid Diseases

NCT02549742 2017-01-18

Electrochemotherapy on Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms

NCT03015727 2017-01-10

IRCNPC

Phase 3 Unknown

Nasopharyngeal Carcinoma